论文部分内容阅读
目的:探究与分析布地奈德雾化吸入治疗小儿肺炎的临床疗效观察。方法:选取我院自2013年4月至2015年4月収治的90例小儿肺炎患者,采取随机数字表法分为布地奈德组与常规综合组,每组各45例,对比两者的临床疗效及症状消失时间。结果:常规综合组的总有效率为75.67%,布地奈德组的总有效率为93.33%,布地奈德组的总有效率明显高于常规综合组(P<0.05)。布地奈德组咳嗽、气喘、肺部哮鸣音症状消失时间均明显短于常规综合组(P<0.05)。结论:采用布地奈德雾化吸入治疗小儿肺炎的临床疗效显著,症状消失时间明显缩短,值得广泛推广与应用。
Objective: To investigate and analyze the clinical efficacy of budesonide inhalation in treating children pneumonia. Methods: Ninety children with pneumonia admitted from April 2013 to April 2015 in our hospital were randomly divided into the budesonide group and the conventional combined group, with 45 cases in each group. The clinical data of two groups were compared Efficacy and symptoms disappear time. Results: The total effective rate was 75.67% in the conventional combined group and 93.33% in the budesonide group. The total effective rate in the budesonide group was significantly higher than that in the conventional combined group (P <0.05). Budesonide group cough, asthma, lung wheeze symptoms disappeared significantly shorter than the conventional combination group (P <0.05). Conclusion: The clinical efficacy of inhaled budesonide inhalation in treating children with pneumonia is significant, and the disappearance of symptoms time is obviously shortened, which is worthy of wide application and promotion.